Lake Bluff, IL, United States of America

Robert C Goldman

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert C Goldman. Retrieved from https://idiyas.com/inventor/robert-c-goldman-i3kgluqs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert C Goldman

Introduction

Robert C Goldman is a notable inventor based in Lake Bluff, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit Candida acid protease. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing science.

Latest Patents

Goldman's most recent patent focuses on Candida acid protease inhibiting compounds. The patent describes compounds that have the formula: ##STR1## wherein R.sub.1 is loweralkyl, loweralkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, arylalkyl, or (heterocyclic)alkyl. This patent highlights his expertise in creating solutions that target specific biochemical processes.

Career Highlights

Robert C Goldman is associated with Abbott Laboratories Corporation, a leading global healthcare company. His role at Abbott has allowed him to work on groundbreaking research and development projects. With a total of 1 patent to his name, Goldman has established himself as a valuable contributor to the field.

Collaborations

Throughout his career, Goldman has collaborated with esteemed colleagues such as Biswanath De and William R Baker. These partnerships have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Robert C Goldman exemplifies the spirit of innovation through his work in biochemistry and his contributions to the development of Candida acid protease inhibiting compounds. His career at Abbott Laboratories Corporation and collaborations with other professionals further highlight his impact on the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…